14 November 2018 in BioMed Research International
Introduction. Pretreatment platelet-to-lymphocyte ratio (PLR) has been considered a prognostic factor in various cancers. However, the application of PLR in the assessment of patients with cholangiocarcinoma remains controversial. This study aimed to evaluate the prognostic value of pretreatment PLR in cholangiocarcinoma. Methods. A systematic search was performed in MEDLINE, EMBASE, and Cochrane Library to identify studies assessing the prognostic significance of the pretreatment PLR in cholangiocarcinoma. Three databases were searched from inception to August 5, 2018. The primary outcome was overall survival (OS), and the secondary outcomes were recurrence-free survival (RFS) and progression-free survival (PFS). Pooled hazard ratios (HRs) or odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using random-effects models. Results. A total of 9 studies including 2395 patients were finally enrolled in the meta-analysis based on the inclusion and exclusion criteria. All of the included studies were retrospective observational cohorts. Elevated PLR predicted poor OS (HR: 1.38, 95% CI: 1.19-1.62, P < 0.001) and RFS or PFS (HR = 1.55; 95% CI = 1.27-1.88; P < 0.001). Moreover, elevated PLR was highly associated with male sex (male versus female OR = 0.59, 95% CI: 0.44-0.80, P < 0.001) and R1 resection margin (OR = 2.09, 95% CI: 1.24-3.54, P = 0.006). Conclusion. The present meta-analysis demonstrated that pretreatment PLR might serve as a useful prognostic biomarker in cholangiocarcinoma.
13 December 2018 in arXiv
Objective: Numerous glucose prediction algorithm have been proposed to empower type 1 diabetes (T1D) management. Most of these algorithms only account for input such as glucose, insulin and carbohydrate, which limits their performance. Here, we present a novel glucose prediction algorithm which, in addition to standard inputs, accounts for meal absorption and physical exercise information to enhance prediction accuracy. Methods: a compartmental model of glucose-insulin dynamics combined with a deconvolution technique for state estimation is employed for glucose prediction. In silico data corresponding from the 10 adult subjects of UVa-Padova simulator, and clinical data from 10 adults with T1D were used. Finally, a comparison against a validated glucose prediction algorithm based on a latent variable with exogenous input (LVX) model is provided. Results: For a prediction horizon of 60 minutes, accounting for meal absorption and physical exercise improved glucose forecasting accuracy. In particular, root mean square error (mg/dL) went from 26.68 to 23.89, p<0.001 (in silico data); and from 37.02 to 35.96, p<0.001 (clinical data - only meal information). Such improvement in accuracy was translated into significant improvements on hypoglycaemia and hyperglycaemia prediction. Finally, the performance of the proposed algorithm is statistically superior to that of the LVX algorithm (26.68 vs. 32.80, p<0.001 (in silico data); 37.02 vs. 49.17, p<0.01 (clinical data). Conclusion: Taking into account meal absorption and physical exercise information improves glucose prediction accuracy.